Back to Journals » OncoTargets and Therapy » Volume 12

Complete response to crizotinib in a metastatic adenocarcinoma of unknown primary harboring MET amplification and NTRK1 co-occurring mutation

Total article views   HTML views PDF downloads Totals
5,009 Dovepress* 4,566+ 766 5,332
PubMed Central* 443 132 575
Totals 5,009 898 5,907
*Since 29 May 2019

View citations on PubMed Central and Google Scholar